High-Cost Medicines in Saudi Arabia — Regulatory Information
This page sets out the regulatory route, the documentation and who may handle high-cost prescription medicines in Saudi Arabia. It is informational: it contains no pricing and no offer of sale.
Prescription-only medicine. No pricing is published on this page. Prescription-medicine pricing is not advertised to the public in this market.
This page is informational and is not an advertisement, a promotional communication, or medical advice. It does not offer any medicine for sale to the public. Treatment decisions belong to your treating physician.
The regulatory route in Saudi Arabia
Medicines in Saudi Arabia are regulated by the Saudi Food and Drug Authority (SFDA). Every product described on this site is a prescription-only medicine, supplied against a valid prescription from a treating physician and dispensed through licensed channels. Nothing on this page is an offer to sell to the public.
Controlled medicines carried by travellers run through the SFDA's Controlled Drugs System (CDS) at cds.sfda.gov.sa. The SFDA published its Guideline for Clearance Permit of Controlled Drugs for Travelers on 14 August 2025, which sets out the electronic clearance request process.
Saudi Arabia updated its personal-import and prescription rules in December 2024. Confirm the current requirements directly with the SFDA before applying.
The SFDA publishes registration data for locally manufactured and non-local human medicines as open data. It does not publish a medicine price dataset, so any site presenting an "official SFDA price" for a specific product is not drawing on a published SFDA source. The SFDA also publishes drug circulars, withdrawal notices and current shortage information in Arabic — worth checking first, because a national shortage is the most common reason a prescribed medicine cannot be dispensed locally.
Medicines covered (35)
Immunotherapy (Checkpoint Inhibitors)
Antibody–Drug Conjugates (ADC)
Targeted Therapy
Immunomodulators
Tyrosine Kinase & Kinase Inhibitors
Hormonal Therapy
CDK4/6 Inhibitors
HER2-Targeted Therapy
PARP Inhibitors
Neurology & Rare Disease
Background reading
Prescription-based enquiry
If you hold a valid prescription from a treating physician in Saudi Arabia, you can send us the prescription details and we will reply with the regulatory and documentation position for that specific product. We do not publish pricing for Saudi Arabia and we do not sell to the public.
Send a prescription-based enquiryMedically reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-07-29
For healthcare professionals
Prescribers, hospital and specialty pharmacies, oncology centres and procurement departments: named patient supply, documentation and the sourcing workflow.